Eli Lilly and Company announced that it has completed the acquisition of Alnara Pharmaceuticals, Inc., a privately-held company developing protein therapeutics for the treatment of metabolic diseases.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, announced initiation of a Phase 2 clinical trial of hGH-CTP, the company’s proprietary biobetter version of human growth hormone (hGH).
NovaBay Pharmaceuticals, Inc. announced results from a Phase 2a trial that show its lead product candidate is safe and efficacious against the highly contagious skin infection impetigo, including those infections caused by drug-resistant MRSA.
A long-standing question in bone biology has been answered: It is the spindly extensions of bone cells that sense mechanical stimulation and signal the release of bone-growth factors.
If mice are administered an antibiotic for three days and are simultaneously infected with malaria, no parasites appear in the blood and life-threatening disease is averted. In addition, the animals treated in this manner also develop robust, long-term immunity against subsequent infections.
Implanting tiny plastic scaffolds seeded with genetically engineered stem cells reduced organ damage and led to better cardiac function after a heart attack, according to a recent animal study.
By swapping out one specific hydrogen atom for an isotope twice as heavy, researchers have increased the shelf life and detection ability of fluorescent probes that are essential to studying a variety of inflammatory diseases, including cancer and atherosclerosis.
Researchers at UT Southwestern Medical Center have found that blocking one of the enzymatic steps that allow prostate tumors to produce androgens could be the key in halting the cancer's growth.
Gilead Sciences, Inc. announced that its total revenues for the second quarter of 2010 were $1.93 billion, up 17% compared to total revenues of $1.65 billion for the second quarter of 2009.
A panel of cancer experts said that the government should remove its endorsement of Roche's drug Avastin for breast cancer, after follow-up studies failed to show benefits for patients.
GlaxoSmithKline, the world's second-largest pharmaceutical company by revenue, reported a loss of $464 million for the second quarter as the company absorbed a hit of $2.4 billion for settling lawsuits.
Abbott Laboratories said its net income was unchanged in the second quarter as greater expenses canceled out higher revenue from Abbott's drugs and medical devices and from companies it recently acquired.
Veeco Instruments Inc. announces the release of the IRIS models for Innova and BioScope Catalyst atomic force microscopes to provide superior integration and accessibility for combined atomic force microscopy and Raman spectroscopy research.
AMSBIO has announced a new range of MagSi magnetic beads that incorporate a novel ferro fluid to combine the advantages of small beads and large surface with the magnetic performance and strength of larger beads.
Pharsight has named five leading universities as Phoenix Centers of Excellence as part of its continuing collaboration with academic departments and research organizations worldwide.